Status:
TERMINATED
Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's Disease
Lead Sponsor:
Peter Tass, MD, PhD
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a study to evaluate peripheral vibrotactile coordinated reset stimulation for Parkinson's disease seeks to explore the safety and efficacy of an experimental non-invasive method to aid in the ...
Detailed Description
This study aims to evaluate the safety and efficacy of a non-invasive, experimental method to aid in the symptoms of Parkinson's disease. A glove device produces non-painful sensory (tactile) vibrator...
Eligibility Criteria
Inclusion
- Age 18 and older
- Diagnosis of idiopathic Parkinson's disease.
- Levodopa responsiveness as defined by at least a 30% reduction in Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor subscale (excluding tremor scores) in the ON vs off medication state.
- Willing to participate in the vibrotactile stimulation sessions for 2 consecutive days initially and willing to return for follow-up visits
- Able to provide informed consent.
- Appropriate social support
Exclusion
- Hoehn and Yahr stage greater than 3 in the on medication state
- Presence of other forms of non-idiopathic parkinsonism, including but not limited to atypical parkinsonism, medication induced parkinsonism, vascular Parkinsonism
- Any illness that in the investigator's opinion precludes participation in the study
- Subjects unable to communicate with the investigator and staff
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT03857867
Start Date
February 1 2019
End Date
December 30 2020
Last Update
December 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305